Simcere Pharmaceutical Group Limited (HKG:2096)

Hong Kong · Delayed Price · Currency is HKD

9.63

-0.24 (-2.43%)

Jun 8, 2026, 4:09 PM HKT

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2012
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '12 Dec 31, 2012
Intersegment Elimination	-94.61M	-42.73M	-	-	-
Anti-oncology Business	2.02B	1.30B	-	-	-
Anti-oncology Business Growth	56.24%	-	-	-	-
Other Pharmaceutical Business	5.80B	5.38B	-	-	-
Other Pharmaceutical Business Growth	7.79%	-	-	-	-
Pharmaceuticals	-	-	6.61B	6.32B	5.00B
Pharmaceuticals Growth	-	-	4.49%	26.49%	10.89%
Total	7.73B	6.64B	6.61B	6.32B	5.00B
Total Growth	16.52%	0.41%	4.49%	26.49%	10.89%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2012
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '12 Dec 31, 2012
People's Republic of China (PRC)	7.73B	6.64B	6.61B	6.32B	5.00B
People's Republic of China (PRC) Growth	16.52%	0.41%	4.49%	26.49%	10.89%
Total	7.73B	6.64B	6.61B	6.32B	5.00B
Total Growth	16.52%	0.41%	4.49%	26.49%	10.89%

Source: S&P Global Market Intelligence.